Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXT6YC
|
||||
| Drug Name |
N-[(3R)-1-cyano-3-pyrrolidinyl]-2,5-bis(methyloxy)benzenesulfonamide
|
||||
| Synonyms |
CHEMBL1672426
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C13H17N3O4S
|
||||
| Canonical SMILES |
COc1ccc(OC)c(c1)S(=O)(=O)N[C@@H]2CCN(C2)C#N
|
||||
| InChI |
InChI=1S/C13H17N3O4S/c1-19-11-3-4-12(20-2)13(7-11)21(17,18)15-10-5-6-16(8-10)9-14/h3-4,7,10,15H,5-6,8H2,1-2H3/t10-/m1/s1
|
||||
| InChIKey |
SRQKADSCZJGWOI-SNVBAGLBSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.